Cathie Wood offloads two big winners in surprise move

TheStreetTuesday, September 23, 2025 at 12:33:00 PM
Cathie Wood offloads two big winners in surprise move
In a surprising turn of events, Cathie Wood, the founder of ARK Invest, has decided to offload two of her major winning stocks. This move raises eyebrows in the investment community, as it suggests a shift in strategy or concerns about the future performance of these companies. Investors often look to Wood's decisions as indicators of market trends, making this development particularly noteworthy.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Cathie Wood says the AI race has already shrunk to the ‘Big 4’ key players, and it could soon drop to 2
NeutralFinancial Markets
Cathie Wood has pointed out that the artificial intelligence landscape is rapidly consolidating, with only four major players currently dominating the field. This shift is significant as it suggests that the competition may soon narrow even further, potentially down to just two key players. Understanding this trend is crucial for investors and tech enthusiasts alike, as it could reshape the future of AI development and investment opportunities.
Cathie Wood's ARK ETF adjusts, buys Alibaba, sells Shopify stock
PositiveFinancial Markets
Cathie Wood's ARK ETF has made notable adjustments to its portfolio, purchasing shares of Alibaba while selling off its stake in Shopify. This move reflects Wood's strategic approach to investing, focusing on companies she believes have strong growth potential. The decision to buy Alibaba, a major player in the e-commerce sector, indicates confidence in its future performance, especially as it navigates the competitive landscape. Meanwhile, divesting from Shopify suggests a shift in priorities, possibly in response to market trends or company performance. Such adjustments are significant as they highlight the dynamic nature of investment strategies in today's market.
Trump’s $100K visa move ‘threw a lot of people, including us,’ Cathie Wood says. She’s still wildly optimistic about the American economy
NeutralFinancial Markets
Cathie Wood, CEO of ARK Invest, expressed her views on Trump's recent $100K visa move, describing it as a short-term action that has confused many, including her team. She believes this decision serves as a punishment for India but remains optimistic about the overall American economy. Wood emphasizes the importance of productivity as a key factor in combating inflation, highlighting her confidence in the nation's economic resilience despite political challenges.
In Full: Ark's Wood on H-1B Visas, China Tech, TikTok
NeutralFinancial Markets
Cathie Wood, the founder and CEO of Ark Investment Management, shared her insights on Bloomberg Television regarding the implications of President Trump's decision to limit H-1B visas and its potential effects on Silicon Valley. She also highlighted the competitive landscape in artificial intelligence and discussed the unique situation surrounding the U.S. acquisition of TikTok from its Chinese owners. This conversation is significant as it touches on key issues affecting the tech industry and immigration policies.
Latest from Financial Markets
Russians ramp up spending on foreign holidays – data
PositiveFinancial Markets
Recent data shows that Russians are significantly increasing their spending on foreign holidays, with Türkiye emerging as the top travel destination. This trend highlights a growing interest in international travel among Russians, which could have positive implications for the tourism industry and local economies in popular destinations.
F.D.A.’s Approval of Drug for Autism Upends Review Process
PositiveFinancial Markets
The FDA's recent approval of a new drug for autism marks a significant shift in the review process for treatments targeting this condition. This decision not only opens doors for innovative therapies but also highlights the growing recognition of autism in the healthcare landscape. It matters because it could lead to improved quality of life for individuals with autism and their families, offering hope where there was previously limited options.
Drone Swarm Software Maker Auterion Raises $130 Million
PositiveFinancial Markets
Auterion, a defense tech startup, has successfully raised $130 million in a Series B funding round, signaling strong investor confidence in its innovative drone software. This funding will enable Auterion to expand its technology for drone warfare, which is increasingly relevant in modern defense strategies. CEO Lorenz Meier discussed the implications of this funding on Bloomberg Tech, highlighting the potential for enhanced capabilities in military operations. This development is significant as it reflects the growing importance of advanced technology in defense and security.
FAT Brands engages advisers amid restructuring talks with bondholders - WSJ
NeutralFinancial Markets
FAT Brands is currently in discussions with advisers as it navigates restructuring talks with its bondholders. This development is significant as it highlights the company's efforts to manage its financial obligations and stabilize its operations. The outcome of these talks could impact the future of the brand and its ability to continue expanding in the competitive food industry.
Trump Blasts UN Over Immigration, Climate
NegativeFinancial Markets
In a fiery address at the United Nations General Assembly, President Donald Trump criticized the UN for not supporting his diplomatic initiatives, dismissing climate change as a hoax and labeling uncontrolled migration as the foremost political issue today. This speech highlights Trump's ongoing tension with international bodies and his controversial stance on global issues, which could impact future diplomatic relations and global cooperation.
Trump links autism to Tylenol and vaccines, claims not backed by science
NegativeFinancial Markets
Former President Donald Trump has stirred controversy by linking autism to the use of Tylenol and vaccines, a claim that lacks scientific backing. This assertion raises concerns as it may contribute to misinformation about autism and vaccine safety, potentially influencing public perception and health decisions. It's crucial to rely on credible scientific research when discussing such sensitive topics.